Searched for
GLENMARK ACCESS
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- Glenmark launches fixed-dose triple therapy for COPDGlenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment combines three...
- Glenmark inks licensing pact with Jiangsu Alphamab, 3D Medicines for cancer drugGlenmark Pharmaceuticals Ltd announced that its subsidiary, Glenmark Specialty S A (GSSA), has entered into a license agreement with Jiangs...
- Glenmark Pharmaceuticals acquires certain OTC drugs from Wockhardt in US"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs re...
- Glenmark Pharma inks exclusive licensing agreement with Lotus InternationalGlenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.
- Glenmark launches unique fixed dose combination drug for diabetesThe Mumbai based drug firm said it has introduced fixed dose combination (FDC) of its novel, patent protected Sodium Glucose Co-Transporter...
- Glenmark Pharma launches COPD treatment inhaler in UKDrug firm Glenmark Pharma on Tuesday announced the launch of Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstru...
- Glenmark Pharma launches nasal spray Ryaltris in IndiaGlenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost fo...
- Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...
- DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFluDrug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action.
- Glenmark Pharma launches anti-diabetes drug Remogliflozin in IndiaGlenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.
- Glenmark Pharma gets BSE nod to merge subsidiaries with itselfThe approval is valid for six months, during which the company will apply to the High Court for further clearance of the proposal.
- Glenmark Pharma gets board nod to merge two subsidiaries with itselfGlenmark Pharmaceuticals' board today approved a merger of two subsidiaries -- Glenmark Generics and Glenmark Access -- with itself.
- Glenmark inks drug development pact with Forest LaboratoriesAs part of the agreement, Glenmark will receive up to $ 9 million (around Rs 50 crore) from US-based Forest Laboratories Inc.
- Glenmark buys 7 Polish brands from ActavisGlenmark Pharmaceuticals on Wednesday said its European arm, Medicamenta, has acquired seven pharmaceutical brands from Iceland-based gener...
- Glenmark acquires 7 pharmaceutical brands in PolandDrug maker Glenmark Pharmaceuticals today said it has signed agreements with Iceland-based Actavis to acquire seven pharmaceutical brands i...
Load More
